# VOSTALLY
> **NDA219757** · New Drug Application · Sponsor: ROSEMONT PHARMS · Approved 2025-07-23
## Drug
- **FDA Application Number:** NDA219757
- **Application type:** New Drug Application
- **Brand name:** VOSTALLY
- **Generic name:** Ramipril
- **Active ingredients:** RAMIPRIL
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ROSEMONT PHARMS
- **First approval:** 2025-07-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219757)
---
*AI Analytics · CC0 1.0*